In the late afternoon on Tuesday, Carol Bartz, executive chairman of the board of Autodesk Inc. was confirmed as the new CEO of Yahoo! Inc. by the online company itself.

It has been learnt that Bartz will immediately start with the new role as CEO and a member of Yahoo!'s board of directors.

Via a statement, Roy Bostock, Chairman of Yahoo!'s board informed, “We are very excited to have Carol Bartz leading Yahoo! into its next era of growth. She is the exact combination of seasoned technology executive and savvy leader that the board was looking for.”

National Thermal Power Corporation Ltd (NTPC) has signed a Joint Venture agreement with five large state-run companies. The list includes Steel Authority of India Ltd (SAIL), Rashtriya Ispat Nigam Ltd (RINL), Coal India Ltd (CIL) and National Mineral Development Corporation Ltd (NMDC).

Kolkata-based Braj Binani Group cement manufacturer, Binani Cement Ltd. has entered into a Memorandum of Understanding (MOU) with the Gujarat Government to set up a Greenfield cement plant of 2.5 MTPA capacity in the state.

The plant will manufacture Ordinary Portland Cement (OPC), Pozzolona Portland Cement (PPC) in various grades. It may be noted that the production of OPC to PPC will be ordinarily 50:50.

Hindustan Construction Company (HCC), one of the leading construction and civil engineering firm, has signed two MoUs with Gujarat Government for a total investment of Rs 41,500 cr.

The company stated in an official release that it has signed the first MoU with the Gujarat Government Infrastructure Board, to develop a water front city with a total investment of Rs 40,000 crore.

Sources revealed that the proposed new city will be on the lines of Lavasa, India's first hill city being built by the company near Pune, Maharastra.

Jubilant Organosys, an integrated pharmaceutical industry player, has notified that its Bangalore-based subsidiary Jubilant Biosys Ltd, has entered into a drug discovery partnership with BioLeap, LLC, USA.

Under the relationship, BioLeap and Jubilant will integrate BioLeap's leading edge computational fragment based drug design platform with Jubilant's expertise in chemistry, biology and crystallography to offer a highly competitive preclinical drug development platform.

Cambridge Solutions Limited has informed that its wholly owned subsidiary, Cambridge Integrated Services Group has entered into a significant new contract with Compagnie Pour Assistance Technique et Investissements S. A. (CATISA), to provide consulting services, business development and procurement services over the next two years.

The contract has a value of up to US$15 million over this period.